{"pmid":32326986,"title":"Impact of COVID-19 on Mental Healthcare of Older Adults: Insights from Lebanon (Middle East).","text":["Impact of COVID-19 on Mental Healthcare of Older Adults: Insights from Lebanon (Middle East).","Int Psychogeriatr","Khoury, Rita","Karam, Georges","32326986"],"journal":"Int Psychogeriatr","authors":["Khoury, Rita","Karam, Georges"],"date":"2020-04-25T11:00:00Z","year":2020,"_id":"32326986","week":"202017|Apr 20 - Apr 26","doi":"10.1017/S104161022000068X","source":"PubMed","weight":0,"locations":["Lebanon"],"countries":["Lebanon"],"countries_codes":["LBN|Lebanon"],"_version_":1664996914964201474,"score":8.518259,"similar":[{"pmid":32145185,"pmcid":"PMC7155742","title":"Middle East respiratory syndrome.","text":["Middle East respiratory syndrome.","The Middle East respiratory syndrome coronavirus (MERS-CoV) is a lethal zoonotic pathogen that was first identified in humans in Saudi Arabia and Jordan in 2012. Intermittent sporadic cases, community clusters, and nosocomial outbreaks of MERS-CoV continue to occur. Between April 2012 and December 2019, 2499 laboratory-confirmed cases of MERS-CoV infection, including 858 deaths (34.3% mortality) were reported from 27 countries to WHO, the majority of which were reported by Saudi Arabia (2106 cases, 780 deaths). Large outbreaks of human-to-human transmission have occurred, the largest in Riyadh and Jeddah in 2014 and in South Korea in 2015. MERS-CoV remains a high-threat pathogen identified by WHO as a priority pathogen because it causes severe disease that has a high mortality rate, epidemic potential, and no medical countermeasures. This Seminar provides an update on the current knowledge and perspectives on MERS epidemiology, virology, mode of transmission, pathogenesis, diagnosis, clinical features, management, infection control, development of new therapeutics and vaccines, and highlights unanswered questions and priorities for research, improved management, and prevention.","Lancet","Memish, Ziad A","Perlman, Stanley","Van Kerkhove, Maria D","Zumla, Alimuddin","32145185"],"abstract":["The Middle East respiratory syndrome coronavirus (MERS-CoV) is a lethal zoonotic pathogen that was first identified in humans in Saudi Arabia and Jordan in 2012. Intermittent sporadic cases, community clusters, and nosocomial outbreaks of MERS-CoV continue to occur. Between April 2012 and December 2019, 2499 laboratory-confirmed cases of MERS-CoV infection, including 858 deaths (34.3% mortality) were reported from 27 countries to WHO, the majority of which were reported by Saudi Arabia (2106 cases, 780 deaths). Large outbreaks of human-to-human transmission have occurred, the largest in Riyadh and Jeddah in 2014 and in South Korea in 2015. MERS-CoV remains a high-threat pathogen identified by WHO as a priority pathogen because it causes severe disease that has a high mortality rate, epidemic potential, and no medical countermeasures. This Seminar provides an update on the current knowledge and perspectives on MERS epidemiology, virology, mode of transmission, pathogenesis, diagnosis, clinical features, management, infection control, development of new therapeutics and vaccines, and highlights unanswered questions and priorities for research, improved management, and prevention."],"journal":"Lancet","authors":["Memish, Ziad A","Perlman, Stanley","Van Kerkhove, Maria D","Zumla, Alimuddin"],"date":"2020-03-08T11:00:00Z","year":2020,"_id":"32145185","week":"202010|Mar 02 - Mar 08","doi":"10.1016/S0140-6736(19)33221-0","source":"PubMed","topics":["Transmission","Treatment","Diagnosis","Prevention","Mechanism"],"weight":1,"locations":["Saudi Arabia","Jordan","Saudi Arabia","Riyadh","Jeddah","South Korea"],"countries":["Korea, Republic of","Saudi Arabia","Jordan"],"countries_codes":["KOR|Korea, Republic of","SAU|Saudi Arabia","JOR|Jordan"],"_version_":1664640874906124291,"score":87.536064},{"pmid":32213260,"title":"Pharmacologic Treatments and Supportive Care for Middle East Respiratory Syndrome.","text":["Pharmacologic Treatments and Supportive Care for Middle East Respiratory Syndrome.","Available animal and cell line models have suggested that specific therapeutics might be effective in treating Middle East respiratory syndrome (MERS). We conducted a systematic review of evidence for treatment with pharmacologic and supportive therapies. We developed a protocol and searched 5 databases for studies describing treatment of MERS and deaths in MERS patients. Risk of bias (RoB) was assessed by using ROBINS-I tool. We retrieved 3,660 unique citations; 20 observational studies met eligibility, and we studied 13 therapies. Most studies were at serious or critical RoB; no studies were at low RoB. One study, at moderate RoB, showed reduced mortality rates in severe MERS patients with extracorporeal membrane oxygenation; no other studies showed a significant lifesaving benefit to any treatment. The existing literature on treatments for MERS is observational and at moderate to critical RoB. Clinical trials are needed to guide treatment decisions.","Emerg Infect Dis","Kain, Taylor","Lindsay, Patrick J","Adhikari, Neill K J","Arabi, Yaseen M","Van Kerkhove, Maria D","Fowler, Robert A","32213260"],"abstract":["Available animal and cell line models have suggested that specific therapeutics might be effective in treating Middle East respiratory syndrome (MERS). We conducted a systematic review of evidence for treatment with pharmacologic and supportive therapies. We developed a protocol and searched 5 databases for studies describing treatment of MERS and deaths in MERS patients. Risk of bias (RoB) was assessed by using ROBINS-I tool. We retrieved 3,660 unique citations; 20 observational studies met eligibility, and we studied 13 therapies. Most studies were at serious or critical RoB; no studies were at low RoB. One study, at moderate RoB, showed reduced mortality rates in severe MERS patients with extracorporeal membrane oxygenation; no other studies showed a significant lifesaving benefit to any treatment. The existing literature on treatments for MERS is observational and at moderate to critical RoB. Clinical trials are needed to guide treatment decisions."],"journal":"Emerg Infect Dis","authors":["Kain, Taylor","Lindsay, Patrick J","Adhikari, Neill K J","Arabi, Yaseen M","Van Kerkhove, Maria D","Fowler, Robert A"],"date":"2020-03-28T11:00:00Z","year":2020,"_id":"32213260","week":"202013|Mar 23 - Mar 29","doi":"10.3201/eid2606.200037","keywords":["cov","mers","middle east respiratory syndrome","acute respiratory distress syndrome","antivirals","convalescent plasma","coronavirus","coronavirus infections","corticosteroids","interferon","intravenous immunoglobulin","respiratory infections","ribavirin","severe acute respiratory syndrome","supportive care","systematic review","viruses","zoonoses"],"source":"PubMed","topics":["Treatment"],"weight":1,"_version_":1664638838319874048,"score":70.29413},{"pmid":32247017,"pmcid":"PMC7118624","title":"Middle East Respiratory Syndrome Coronavirus (MERS-CoV) and COVID-19 infection during pregnancy.","text":["Middle East Respiratory Syndrome Coronavirus (MERS-CoV) and COVID-19 infection during pregnancy.","Travel Med Infect Dis","Al-Tawfiq, Jaffar A","32247017"],"journal":"Travel Med Infect Dis","authors":["Al-Tawfiq, Jaffar A"],"date":"2020-04-05T11:00:00Z","year":2020,"_id":"32247017","week":"202014|Mar 30 - Apr 05","doi":"10.1016/j.tmaid.2020.101641","source":"PubMed","topics":["Diagnosis"],"weight":1,"_version_":1664638040138579969,"score":64.294},{"pmid":32325036,"title":"Two Middle East respiratory syndrome vaccines: first step for other coronavirus vaccines?","text":["Two Middle East respiratory syndrome vaccines: first step for other coronavirus vaccines?","Lancet Infect Dis","Modjarrad, Kayvon","Kim, Jerome H","32325036"],"journal":"Lancet Infect Dis","authors":["Modjarrad, Kayvon","Kim, Jerome H"],"date":"2020-04-24T11:00:00Z","year":2020,"_id":"32325036","week":"202017|Apr 20 - Apr 26","doi":"10.1016/S1473-3099(20)30317-0","source":"PubMed","topics":["Treatment"],"weight":1,"_version_":1664895932822454272,"score":63.991882},{"pmid":32085843,"pmcid":"PMC7128970","title":"Mental health services for older adults in China during the COVID-19 outbreak.","text":["Mental health services for older adults in China during the COVID-19 outbreak.","Lancet Psychiatry","Yang, Yuan","Li, Wen","Zhang, Qinge","Zhang, Ling","Cheung, Teris","Xiang, Yu-Tao","32085843"],"journal":"Lancet Psychiatry","authors":["Yang, Yuan","Li, Wen","Zhang, Qinge","Zhang, Ling","Cheung, Teris","Xiang, Yu-Tao"],"date":"2020-02-23T11:00:00Z","year":2020,"_id":"32085843","week":"20208|Feb 17 - Feb 23","doi":"10.1016/S2215-0366(20)30079-1","source":"PubMed","weight":0,"locations":["China"],"countries":["China"],"countries_codes":["CHN|China"],"_version_":1664640875203919874,"score":63.925625}]}